Evaluation of drug influence on the itch duration in the skin of patients with atopic dermatitis, various eczemas and psoriasis. I. Experiments in involved skin. Comparison with itch threshold technique.
D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004485:Eczema / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008728:Methotrimeprazine / Q000008:administration & dosage; D010640:Phenothiazines / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage*; D010919:Placebos; D011398:Promethazine / Q000008:administration & dosage; D011537:Pruritus / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D011759:Pyrrolidines / Q000008:administration & dosage; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D010640:Phenothiazines; D010879:Piperazines; D010919:Placebos; D011759:Pyrrolidines; D014149:Tranquilizing Agents; D008728:Methotrimeprazine; D011398:Promethazine